SEC Comment Letter for AVANOS MEDICAL, INC. (AVNS) (CIK 0001606498) (AVNS) — Jan 12, 2022

AVANOS MEDICAL, INC. (AVNS) (CIK 0001606498)
Date: Jan. 12, 2022 · CIK: 0001606498 · Accession: 0000000000-22-000369

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-36440

Date

January 12, 2022

Author

Not clearly detected

Form

UPLOAD

Company

AVANOS MEDICAL, INC. (AVNS) (CIK 0001606498)

Letter

United States securities and exchange commission logo January 12, 2022 Michael Greiner Senior Vice President and Chief Financial Officer Avanos Medical, Inc. 5405 Windward Parkway Alpharetta, Georgia 30004 Re:Avanos Medical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2020 File No. 001-36440 Dear Mr. Greiner: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
January 12, 2022
Michael Greiner
Senior Vice President and Chief Financial Officer
Avanos Medical, Inc.
5405 Windward Parkway
Alpharetta, Georgia 30004
Re:Avanos Medical, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2020
File No. 001-36440
Dear Mr. Greiner:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io